Pediatrix Medical Group Inc
For the period ended Dec 31, 2024. Filed Feb 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 20, 2025
MD$31.62+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets at December 31, 2024 and 2023
(in thousands, except share data)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $229,940 | $73,258 |
| Short-term investments | 118,566 | 104,485 |
| Accounts receivable, net | 259,990 | 272,313 |
| Prepaid expenses | 13,410 | 13,525 |
| Income taxes receivable | 12,614 | 7,565 |
| Other current assets | 5,087 | 12,308 |
| Total current assets | 639,607 | 483,454 |
| Property and equipment, net | 39,172 | 75,639 |
| Goodwill | 1,242,606 | 1,384,166 |
| Intangible assets, net | 11,595 | 21,240 |
| Operating and finance lease right-of-use assets | 39,267 | 70,294 |
| Deferred income tax assets | 103,855 | 102,852 |
| Other assets | 76,598 | 82,165 |
| Total assets | $2,152,700 | $2,219,810 |
| LIABILITIES & SHAREHOLDERS' EQUITY | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $398,690 | $350,798 |
| Current portion of debt and finance lease liabilities, net | 20,545 | 14,913 |
| Current portion of operating lease liabilities | 12,704 | 21,076 |
| Income taxes payable | 2,171 | 2,159 |
| Total current liabilities | 434,110 | 388,946 |
| Long-term debt and finance lease liabilities, net | 597,119 | 618,421 |
| Long-term operating lease liabilities | 31,945 | 47,238 |
| Long-term professional liabilities | 257,455 | 251,284 |
| Deferred income tax liabilities | 34,246 | 34,308 |
| Other liabilities | 32,887 | 30,552 |
| Total liabilities | 1,387,762 | 1,370,749 |
| Commitments and contingencies | ||
| Shareholders’ equity: | ||
| Preferred stock; $.01 par value; 1,000,000 shares authorized; none issued | — | — |
| Common stock; $.01 par value; 200,000,000 shares authorized; 85,866,000 and 84,018,023 shares issued and outstanding, respectively | 859 | 840 |
| Additional paid-in capital | 1,013,690 | 999,906 |
| Accumulated other comprehensive loss | (1,071) | (2,214) |
| Retained deficit | (248,540) | (149,471) |
| Total shareholders’ equity | 764,938 | 849,061 |
| Total liabilities and shareholders' equity | $2,152,700 | $2,219,810 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.